CTOs on the Move

Ossio

www.ossio.io

 
Ossio is an orthopedic medical device company founded in Israel in 2014 with the vision to completely transform the orthopedic experience for physicians, patients, and payors. Ossio`s mission is to replace metal implants as the standard of care in the $10B+ orthopedic fixation market (screws, pins, plates) with an intelligent bone regeneration technology.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.ossio.io
  • 300 TradeCenter Suite 3690
    Woburn, MA USA 01801
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Ossio raised $22M on 03/11/2019

Similar Companies

Inergetics

Inergetics is a leading developer of advanced proprietary nutritional products that improve overall health, physical recovery, athletic performance and quality of life for patients and consumers. Whether it`s maintaining a healthy diet, gaining strength, increasing energy, or helping to maintain your activity level at an advanced age, Inergetics offers a line of nutritional supplement that fits your lifestyle, and which you can consistently rely on.

Neovasc

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.

PharmEcology Associates

PharmEcology Associates is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medwave

Medwave Corp. is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Covalon Technologies

Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon`s patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon`s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.